Rick Wise
Stock Analyst at Stifel
(4.23)
# 435
Out of 5,139 analysts
263
Total ratings
63.08%
Success rate
10.66%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $46 | $44.12 | +4.26% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $2.64 | +13.64% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $79.48 | +32.11% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $5.30 | +50.94% | 6 | Jan 7, 2026 | |
| LIVN LivaNova | Maintains: Buy | $65 → $70 | $62.11 | +12.70% | 7 | Jan 7, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $90 → $95 | $81.75 | +16.21% | 3 | Jan 7, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $100 → $105 | $84.35 | +24.48% | 28 | Jan 7, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $210 → $215 | $207.11 | +3.81% | 9 | Jan 7, 2026 | |
| HTFL HeartFlow | Maintains: Buy | $35 → $40 | $37.16 | +7.64% | 2 | Nov 13, 2025 | |
| JNJ Johnson & Johnson | Maintains: Hold | $165 → $190 | $218.66 | -13.11% | 7 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $18.35 | +8.99% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $96.76 | +8.52% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $43.39 | +6.02% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $118 | $87.31 | +35.15% | 16 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $20.11 | +24.32% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.77 | +182.49% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $41.57 | +32.31% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $121.76 | +19.09% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $22.85 | +22.54% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $39.06 | +22.89% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $120 | $88.07 | +36.26% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $363.78 | +20.95% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $535.00 | +14.02% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $142.06 | +33.75% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $8.25 | +45.54% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $88.24 | -15.00% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $20.16 | +19.05% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.34 | +102.59% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $46.94 | +138.60% | 5 | Oct 2, 2020 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $44.12
Upside: +4.26%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $2.64
Upside: +13.64%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $79.48
Upside: +32.11%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $5.30
Upside: +50.94%
LivaNova
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $62.11
Upside: +12.70%
GE HealthCare Technologies
Jan 7, 2026
Maintains: Buy
Price Target: $90 → $95
Current: $81.75
Upside: +16.21%
Edwards Lifesciences
Jan 7, 2026
Maintains: Buy
Price Target: $100 → $105
Current: $84.35
Upside: +24.48%
Becton, Dickinson and Company
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $207.11
Upside: +3.81%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $37.16
Upside: +7.64%
Johnson & Johnson
Oct 15, 2025
Maintains: Hold
Price Target: $165 → $190
Current: $218.66
Upside: -13.11%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $18.35
Upside: +8.99%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $96.76
Upside: +8.52%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $43.39
Upside: +6.02%
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $87.31
Upside: +35.15%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $20.11
Upside: +24.32%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.77
Upside: +182.49%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $41.57
Upside: +32.31%
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $121.76
Upside: +19.09%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $22.85
Upside: +22.54%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $39.06
Upside: +22.89%
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $88.07
Upside: +36.26%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $363.78
Upside: +20.95%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $535.00
Upside: +14.02%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $142.06
Upside: +33.75%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $8.25
Upside: +45.54%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $88.24
Upside: -15.00%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $20.16
Upside: +19.05%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.34
Upside: +102.59%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $46.94
Upside: +138.60%